Minghui Pharmaceutical
PrivateLast Round
pre_ipo
Aug 7, 2025
Est. Valuation
$545M
Total Funding Raised
$11.13M
Company Overview
Minghui Pharmaceutical is a biopharmaceutical company that develops transformative medicines for patients with oncology and autoimmune conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Minghui Pharmaceutical Comparables
Compare Minghui Pharmaceutical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TechnoDerma Medicines Inc. | 75% | |
| InnoCare Pharma Limited | 72% | |
| MediLink Therapeutics | 69% |
Minghui Pharmaceutical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| pre_ipo | Aug 7, 2025 | ||||
| Seed | Apr 1, 2018 |
Minghui Pharmaceutical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioTrack Capital | pre_ipo |
| Boyuan Capital | VC Round |
| TF Capital | VC Round, pre_ipo |
| OrbiMed | pre_ipo |
| 5Y Capital | pre_ipo |
| New Day Venture Capital | pre_ipo |
| Qiming Venture Partners | pre_ipo |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 7, 2025
$131M round led by OrbiMed and Qiming Venture Partners.
Minghui Pharmaceutical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Minghui Pharmaceutical's valuation, stock price, and market status.
Is Minghui Pharmaceutical a public or private company?
Minghui Pharmaceutical is a private company.
What is the current stock price of Minghui Pharmaceutical?
Minghui Pharmaceutical is a private company with no public stock price. No recent secondary market data is available.
How much is Minghui Pharmaceutical worth (valuation)?
Minghui Pharmaceutical's valuation is estimated at $545.0M based on funding round data.
Can I buy Minghui Pharmaceutical stock?
Minghui Pharmaceutical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Minghui Pharmaceutical's last funding round?
Minghui Pharmaceutical's most recent funding round was Growth Equity on August 7, 2025.
Who are the main investors in Minghui Pharmaceutical?
Key investors in Minghui Pharmaceutical include OrbiMed, Qiming Venture Partners.
Will Minghui Pharmaceutical IPO soon?
No public IPO plans have been announced for Minghui Pharmaceutical.
How can I track Minghui Pharmaceutical secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Minghui Pharmaceutical's secondary market activity and sign up for updates.